These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3781342)

  • 1. Technical aspects of intraperitoneal chemotherapy in abdominal carcinomatosis.
    Braly P; Doroshow J; Hoff S
    Gynecol Oncol; 1986 Nov; 25(3):319-33. PubMed ID: 3781342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis.
    Sugarbaker PH
    Dis Colon Rectum; 1994 Feb; 37(2 Suppl):S115-22. PubMed ID: 8313782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preliminary results for intraperitoneal chemotherapy in abdominal cancers].
    Sârbu V; Maciuceanu B; Supeanu I; Dima S; Parvu M; Davidescu C; Plesa D; Iusuf T; Aşchie M; Popescu R; Costea D; Pasăre R; Botea F
    Chirurgia (Bucur); 2007; 102(5):549-55. PubMed ID: 18018355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Theoretical and experimental bases for intraperitoneal chemotherapy in abdominal neoplastic processes].
    Marinov L
    Khirurgiia (Sofiia); 1986; 39(4):11-7. PubMed ID: 3784379
    [No Abstract]   [Full Text] [Related]  

  • 5. Iterative procedures combining cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for isolated peritoneal recurrence.
    Vaira M; Robella M; Mellano A; Sottile A; De Simone M
    Int J Hyperthermia; 2014 Dec; 30(8):565-9. PubMed ID: 25430988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis.
    Molucon-Chabrot C; Isambert N; Benoit L; Zanetta S; Fraisse J; Guilland JC; Royer B; Monin-Baroille P; Flesch M; Fargeot P; Coudert B; Mayer F; Fumoleau P; Chauffert B
    Anticancer Drugs; 2006 Nov; 17(10):1211-7. PubMed ID: 17075321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.
    Morgan RJ; Braly P; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Najera L; Johnson D; Doroshow JH
    Gynecol Oncol; 2000 Jun; 77(3):433-8. PubMed ID: 10831355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.
    Pestieau SR; Sugarbaker PH
    Dis Colon Rectum; 2000 Oct; 43(10):1341-6; discussion 1347-8. PubMed ID: 11052509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study.
    Rossi CR; Foletto M; Mocellin S; Pilati P; De SM; Deraco M; Cavaliere F; Palatini P; Guasti F; Scalerta R; Lise M
    Cancer; 2002 Jan; 94(2):492-9. PubMed ID: 11900234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed repeated intraperitoneal chemotherapy after cytoreductive surgery for colorectal and appendiceal carcinomatosis.
    Fajardo AD; Tan B; Reddy R; Fleshman J
    Dis Colon Rectum; 2012 Oct; 55(10):1044-52. PubMed ID: 22965403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy of disseminated forms of breast cancer using platinum derivatives].
    Gorbunova VA; Trofimova NB; Manziuk LV
    Vopr Onkol; 1990; 36(4):455-7. PubMed ID: 2345995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of endometrial cancer with peritoneal carcinomatosis.
    Delotte J; Desantis M; Frigenza M; Quaranta D; Bongain A; Benchimol D; Bereder JM
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():111-4. PubMed ID: 24300558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inguinal canal as an anatomic sanctuary site of relapse in peritoneal carcinomatosis previously treated with intraperitoneal chemotherapy.
    Liberale G; Elias D; Sideris L; Lasser P; Malka D; Sabourin JC; Pocard M
    J Surg Oncol; 2005 Jul; 91(1):73-6. PubMed ID: 15999360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity].
    Foa C; Bondiau PY; Largillier R; Milano G; Magné N
    Rev Med Interne; 2000 Dec; 21(12):1134-5. PubMed ID: 11191685
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the "Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)", the Swiss and Austrian AGO, and the North-Eastern German Society of Gynaecologic Oncology.
    Dueckelmann AM; Fink D; Harter P; Heinzelmann V; Marth C; Mueller M; Reinthaller A; Tamussino K; Wimberger P; Sehouli J
    Arch Gynecol Obstet; 2018 Apr; 297(4):837-846. PubMed ID: 29356953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects of intraperitoneal fluorouracil in patients with optimal residual ovarian cancer after second-look laparotomy: a Gynecologic Oncology Group Study.
    Walton LA; Blessing JA; Homesley HD
    J Clin Oncol; 1989 Apr; 7(4):466-70. PubMed ID: 2926471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: a final report.
    Crookes P; Leichman CG; Leichman L; Tan M; Laine L; Stain S; Baranda J; Casagrande Y; Groshen S; Silberman H
    Cancer; 1997 May; 79(9):1767-75. PubMed ID: 9128994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center.
    Muñoz-Casares FC; Medina-Fernández FJ; Arjona-Sánchez Á; Casado-Adam Á; Sánchez-Hidalgo JM; Rubio MJ; Ortega-Salas R; Muñoz-Villanueva MC; Rufián-Peña S; Briceño FJ
    Eur J Surg Oncol; 2016 Feb; 42(2):224-33. PubMed ID: 26673283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent pelvic arterial infusion with peptichemio, doxorubicin, and cisplatin for locally advanced and recurrent carcinoma of the uterine cervix.
    Scarabelli C; Tumolo S; De Paoli A; Frustaci S; Campagnutta E; Morassut S; Franchin G; Crivellari D; Sopracordevole F; Lo Re G
    Cancer; 1987 Jul; 60(1):25-30. PubMed ID: 3581031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.
    Kelsen D; Karpeh M; Schwartz G; Gerdes H; Lightdale C; Botet J; Lauers G; Klimstra D; Huang Y; Saltz L; Quan V; Brennan M
    J Clin Oncol; 1996 Jun; 14(6):1818-28. PubMed ID: 8656250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.